Hong Zhang
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 23, 2026
A phase I study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of suraxavir marboxil: a novel oral antiviral for influenza.Jing Zhou, Shousheng Yan, Yan Zhao
|Aug 04, 2020
Pharmacokinetics, pharmacodynamics and tolerability of single and multiple doses of janagliflozin, a sodium-glucose co-transporter-2 inhibitor, in Chinese people with type 2 diabetes mellitus.Xiaojiao Li, Xiaoxue Zhu, Jingrui Liu
|Apr 09, 2020
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y<sub>12</sub> inhibitor.Yifan Zhang, Xiaoxue Zhu, Yan Zhan
|Oct 08, 2019
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus.Hong Zhang, Xiaoxue Zhu, Xiaojiao Li
|Aug 10, 2019
Antiviral effects of a niobium-substituted heteropolytungstate on hepatitis B virus-transgenic mice.Qingmei Li, Hong Zhang, Yanfei Qi
|Jul 26, 2018
Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.Hong Zhang, Qingmei Li, Xiaoxue Zhu
Pageof 2
